Literature DB >> 8117017

Comparison between peripherally implanted ports and externally sited catheters for long-term venous access.

A M Pullyblank1, P D Carey, S Z Pearce, A G Tanner, P J Guillou, J R Monson.   

Abstract

In a comparative study, we examined the use of a peripherally implantable venous access system which does not require either central venous cannulation or radiological screening. We compared the complication rate in 85 patients receiving this system with that in 112 similar patients receiving Hickman lines. In addition, we examined the safety and cost implications of using a ward setting instead of full operating facilities for port insertion. There was a 10.7% incidence of early and 37.6% incidence of late complications in the group receiving Hickman lines compared with only 2.4% early complications and 10.6% late complications in those receiving peripherally implantable ports. There was no difference in complication rates between those patients who had the ports inserted in a ward side room compared with those who had their procedure performed in the operating theatre. We have demonstrated the ease and reliability of port insertion in the absence of screening radiology and we therefore suggest the peripheral port as a safe, cost-effective alternative to existing venous access systems.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8117017      PMCID: PMC2502183     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  22 in total

1.  A modified right atrial catheter for access to the venous system in marrow transplant recipients.

Authors:  R O Hickman; C D Buckner; R A Clift; J E Sanders; P Stewart; E D Thomas
Journal:  Surg Gynecol Obstet       Date:  1979-06

2.  Drug extravasation as a complication of venous access ports.

Authors:  W P Reed; K A Newman; M M Applefeld; F J Sutton
Journal:  Ann Intern Med       Date:  1985-06       Impact factor: 25.391

3.  Prolonged venous access for chemotherapy by means of the Hickman catheter.

Authors:  W P Reed; K A Newman; C de Jongh; J C Wade; S C Schimpff; P H Wiernik; J S McLaughlin
Journal:  Cancer       Date:  1983-07-01       Impact factor: 6.860

4.  Risk of infection associated with the use of Broviac and Hickman catheters.

Authors:  J E Begala; K Maher; J D Cherry
Journal:  Am J Infect Control       Date:  1982-02       Impact factor: 2.918

5.  Totally implanted system for intravenous chemotherapy in patients with cancer.

Authors:  J Gyves; W Ensminger; J Niederhuber; M Liepman; E Cozzi; K Doan; S Dakhil; R Wheeler
Journal:  Am J Med       Date:  1982-12       Impact factor: 4.965

6.  Venous access: a prospective, randomized study of the Hickman catheter.

Authors:  L D Wagman; A Kirkemo; M R Johnston
Journal:  Surgery       Date:  1984-03       Impact factor: 3.982

7.  Implantable central venous access system.

Authors:  A Bothe; W Piccione; J J Ambrosino; P N Benotti; J J Lokich
Journal:  Am J Surg       Date:  1984-04       Impact factor: 2.565

8.  Use of modified subcutaneous right-atrial catheter for venous access in leukaemic patients.

Authors:  H A Blacklock; M V Pillai; R S Hill; J R Matthews; A G Clarke; J F Wade
Journal:  Lancet       Date:  1980-05-10       Impact factor: 79.321

9.  Totally implanted venous and arterial access system to replace external catheters in cancer treatment.

Authors:  J E Niederhuber; W Ensminger; J W Gyves; M Liepman; K Doan; E Cozzi
Journal:  Surgery       Date:  1982-10       Impact factor: 3.982

10.  Results from use of 826 vascular access devices in cancer patients.

Authors:  J H Raaf
Journal:  Cancer       Date:  1985-03-15       Impact factor: 6.860

View more
  2 in total

1.  Liver regional continuous chemotherapy: use of femoral or subclavian artery for percutaneous implantation of catheter-port systems.

Authors:  An-Long Zhu; Lian-Xin Liu; Da-Xun Piao; Ya-Xin Lin; Jin-Peng Zhao; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

2.  Applicability of TIVAP versus PICC in non-hematological malignancies patients: A meta-analysis and systematic review.

Authors:  Baiying Liu; Zhiwei Wu; Changwei Lin; Liang Li; Xuechun Kuang
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.